These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 32943998)
1. HKDC1 promotes the tumorigenesis and glycolysis in lung adenocarcinoma via regulating AMPK/mTOR signaling pathway. Wang X; Shi B; Zhao Y; Lu Q; Fei X; Lu C; Li C; Chen H Cancer Cell Int; 2020; 20():450. PubMed ID: 32943998 [TBL] [Abstract][Full Text] [Related]
2. HKDC1 upregulation promotes glycolysis and disease progression, and confers chemoresistance onto gastric cancer. Wang MQ; Chen YR; Xu HW; Zhan JR; Suo DQ; Wang JJ; Ma YZ; Guan XY; Li Y; Zhu SL Cancer Sci; 2023 Apr; 114(4):1365-1377. PubMed ID: 36519789 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of SFXN1 indicates poor prognosis and promotes tumor progression in lung adenocarcinoma. Chen L; Kang Y; Jiang Y; You J; Huang C; Xu X; Chen F Pathol Res Pract; 2022 Sep; 237():154031. PubMed ID: 35878532 [TBL] [Abstract][Full Text] [Related]
4. Negatively Regulated by miR-29c-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Li Y; Liu Y; Jin K; Dong R; Gao C; Si L; Feng Z; Zhang H; Tian H Front Cell Dev Biol; 2021; 9():771824. PubMed ID: 34926459 [No Abstract] [Full Text] [Related]
5. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma. Zhang Z; Huang S; Wang H; Wu J; Chen D; Peng B; Zhou Q Biochem Biophys Res Commun; 2016 Jun; 474(4):673-679. PubMed ID: 27155152 [TBL] [Abstract][Full Text] [Related]
6. HKDC1 enhances the proliferation, migration and glycolysis of pancreatic adenocarcinoma and is linked to immune infiltration. Pang Q; Huang S; Cao J J Cancer; 2024; 15(7):1983-1993. PubMed ID: 38434978 [No Abstract] [Full Text] [Related]
7. Targeting STT3A produces an anti-tumor effect in lung adenocarcinoma by blocking the MAPK and PI3K/AKT signaling pathway. Cheng J; Xia L; Hao X; Gan F; Bai Y; Zhang C; Mao Y; Zhu Y; Pu Q; Park DW; Tavolari S; Mei J; Chen Y; Deng S; Liu L Transl Lung Cancer Res; 2022 Jun; 11(6):1089-1107. PubMed ID: 35832442 [TBL] [Abstract][Full Text] [Related]
8. PSME3 promotes lung adenocarcinoma development by regulating the TGF-β/SMAD signaling pathway. Wang S; Li Y; Jin K; Suda K; Li R; Zhang H; Tian H Transl Lung Cancer Res; 2024 Jun; 13(6):1331-1345. PubMed ID: 38973962 [TBL] [Abstract][Full Text] [Related]
9. Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition. Wu Y; Liu L; Shen X; Liu W; Ma R Cancer Manag Res; 2021; 13():559-570. PubMed ID: 33519235 [TBL] [Abstract][Full Text] [Related]
10. PGC1β Regulates Breast Tumor Growth and Metastasis by SREBP1-Mediated HKDC1 Expression. Chen X; Lv Y; Sun Y; Zhang H; Xie W; Zhong L; Chen Q; Li M; Li L; Feng J; Yao A; Zhang Q; Huang X; Yu Z; Yao P Front Oncol; 2019; 9():290. PubMed ID: 31058090 [No Abstract] [Full Text] [Related]
11. MYG1 promotes proliferation and inhibits autophagy in lung adenocarcinoma cells via the AMPK/mTOR complex 1 signaling pathway. Han X; Li A; Wang W; Du L; Wang C; Huang G Oncol Lett; 2021 Apr; 21(4):334. PubMed ID: 33692866 [TBL] [Abstract][Full Text] [Related]
12. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
13. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D. Sui MH; Zhang WW; Geng DM; Sun DJ Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800 [TBL] [Abstract][Full Text] [Related]
14. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1α/ glycolysis axis in lung adenocarcinoma. Chen Z; Hu Z; Sui Q; Huang Y; Zhao M; Li M; Liang J; Lu T; Zhan C; Lin Z; Sun F; Wang Q; Tan L Int J Biol Sci; 2022; 18(2):522-535. PubMed ID: 35002507 [No Abstract] [Full Text] [Related]
15. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients. Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ Gene; 2020 Mar; 730():144316. PubMed ID: 31884109 [TBL] [Abstract][Full Text] [Related]
16. PITX2 enhances progression of lung adenocarcinoma by transcriptionally regulating WNT3A and activating Wnt/β-catenin signaling pathway. Luo J; Yao Y; Ji S; Sun Q; Xu Y; Liu K; Diao Q; Qiang Y; Shen Y Cancer Cell Int; 2019; 19():96. PubMed ID: 31043858 [TBL] [Abstract][Full Text] [Related]
17. Silencing of An W; Yu F Open Med (Wars); 2022; 17(1):1655-1663. PubMed ID: 36349192 [TBL] [Abstract][Full Text] [Related]
18. TRIB3 Promotes Lung Adenocarcinoma Progression via an Enhanced Warburg Effect. Xing Y; Luo P; Hu R; Wang D; Zhou G; Jiang J Cancer Manag Res; 2020; 12():13195-13206. PubMed ID: 33380827 [TBL] [Abstract][Full Text] [Related]
19. Identification of LBX2 as a novel causal gene of lung adenocarcinoma. Hu J; Bai Y; Zhang Q; Li M; Yin R; Xu L Thorac Cancer; 2020 Aug; 11(8):2137-2145. PubMed ID: 32567804 [TBL] [Abstract][Full Text] [Related]
20. FANCI Cooperates with IMPDH2 to Promote Lung Adenocarcinoma Tumor Growth via a MEK/ERK/MMPs Pathway. Zheng P; Li L Onco Targets Ther; 2020; 13():451-463. PubMed ID: 32021289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]